| Year |
Citation |
Score |
| 1995 |
Gould EM, Curto KA, Craig CR, Fleming WW, Taylor DA. The role of GABAA receptors in the subsensitivity of Purkinje neurons to GABA in genetic epilepsy prone rats. Brain Research. 698: 62-8. PMID 8581504 DOI: 10.1016/0006-8993(95)00813-6 |
0.481 |
|
| 1992 |
Colasanti BK, Craig CR. Reduction of seizure frequency by clonazepam during cobalt experimental epilepsy. Brain Research Bulletin. 28: 329-31. PMID 1596753 DOI: 10.1016/0361-9230(92)90197-6 |
0.367 |
|
| 1992 |
Craig CR, Colasanti BK. Reduction of frequency of seizures by carbamazepine during cobalt experimental epilepsy in the rat. Pharmacology, Biochemistry, and Behavior. 41: 813-6. PMID 1594649 DOI: 10.1016/0091-3057(92)90232-5 |
0.399 |
|
| 1991 |
Gould EM, Craig CR, Fleming WW, Taylor DA. Sensitivity of cerebellar Purkinje neurons to neurotransmitters in genetically epileptic rats. The Journal of Pharmacology and Experimental Therapeutics. 259: 1008-12. PMID 1684811 |
0.533 |
|
| 1990 |
Craig CR, Colasanti BK. An evaluation of the effectiveness of felbamate as an anticonvulsant in the cobalt epileptic rat European Journal of Pharmacology. 183: 513. |
0.312 |
|
| 1988 |
Craig CR, Colasanti BK. A study of pentylenetetrazol kindling in rats and mice. Pharmacology, Biochemistry, and Behavior. 31: 867-70. PMID 3252278 DOI: 10.1016/0091-3057(88)90397-8 |
0.37 |
|
| 1986 |
Craig CR, Colasanti BK. GABA receptors, lipids, and gangliosides in cobalt epileptic focus. Advances in Neurology. 44: 379-91. PMID 3010678 |
0.431 |
|
| 1982 |
Colasanti BK, Lindamood C, Craig CR. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats. Pharmacology, Biochemistry, and Behavior. 16: 573-8. PMID 6280204 DOI: 10.1016/0091-3057(82)90418-X |
0.371 |
|
| 1982 |
Craig CR, Hoover DB, Colasanti BK. REM sleep and seizure distribution in response to diisopropylfluorophosphate during cobalt experimental epilepsy in the rat Federation Proceedings. 41: No. 6160. |
0.329 |
|
| 1981 |
Ross SM, Craig CR. Studies on gamma-aminobutyric acid transport in cobalt experimental epilepsy in the rat. Journal of Neurochemistry. 36: 1006-11. PMID 6782193 DOI: 10.1111/j.1471-4159.1981.tb01693.x |
0.314 |
|
| 1979 |
Lindamood C, Colasanti BK, Craig CR. Effects of marihuana cannabinoids on seizure activity during cobalt experimental epilepsy in the rat Federation Proceedings. 38: No. 2781. |
0.43 |
|
| 1977 |
Hoover DB, Culberson JL, Craig CR. Structural changes in cerebral cortex during cobalt-induced epilepsy in the rat. Neuroscience Letters. 4: 275-80. PMID 19604958 DOI: 10.1016/0304-3940(77)90192-6 |
0.335 |
|
| 1977 |
Hoover DB, Craig CR, Colasanti BK. Cholinergic involvement in cobalt-induced epilepsy in the rat. Experimental Brain Research. 29: 501-13. PMID 913528 DOI: 10.1007/BF00236187 |
0.359 |
|
| 1976 |
Craig CR, Chiu P, Colasanti BK. Effects of diphenylhydantoin and trimethadione on seizure activity during cobalt experimental epilepsy in the rat. Neuropharmacology. 15: 485-9. PMID 980224 DOI: 10.1016/0028-3908(76)90059-9 |
0.429 |
|
| 1976 |
Hoover DB, Colasanti BK, Craig CR. Effects of hemicholinium 3 on the electrocorticogram of naive and cobalt epileptic rats Federation Proceedings. 35: no. 560. |
0.313 |
|
| 1976 |
Bierkamper GG, Craig CR, Cenedella RJ. Cerebral cortical sterol changes in cobalt induced epilepsy Federation Proceedings. 35: No.1867. |
0.352 |
|
| 1974 |
Colasanti BK, Craig CR. Changes in wet shake behavior during the development of cobalt experimental epilepsy in the rat Pharmacologist. 16: PS 9. |
0.348 |
|
| 1973 |
Colasanti BK, Craig CR. Brain concentrations and synthesis rates of biogenic amines during chronic cobalt experimental epilepsy in the rat. Neuropharmacology. 12: 221-31. PMID 4698421 DOI: 10.1016/0028-3908(73)90106-8 |
0.321 |
|
| 1973 |
Hunt WA, Craig CR. Alterations in cation levels and Na-K ATPase activity in rat cerebral cortex during the development of cobalt-induced epilepsy. Journal of Neurochemistry. 20: 559-67. PMID 4266862 |
0.5 |
|
| 1973 |
Wenger GR, Stitzel RE, Craig CR. The role of biogenic amines in the reserpine-induced alteration of minimal electroshock seizure thresholds in the mouse. Neuropharmacology. 12: 693-703. PMID 4147164 DOI: 10.1016/0028-3908(73)90122-6 |
0.562 |
|
| 1973 |
Bierkamper GG, Craig CR, Cenedella RJ. Changes in cerebral cortical lipids in cobalt induced epilepsy Pharmacologist. 15: 577. |
0.318 |
|
| 1973 |
Colasanti BK, Craig CR. EEG and behavioral correlates of chronic cobalt experimental epilepsy in the rat Federation Proceedings. 32: I. |
0.309 |
|
| 1972 |
Goldberg AM, Pollock JJ, Hartman ER, Craig CR. Alterations in cholinergic enzymes during the development of cobalt-induced epilepsy in the rat. Neuropharmacology. 11: 253-9. PMID 5025828 DOI: 10.1016/0028-3908(72)90097-4 |
0.336 |
|
| 1972 |
Azzaro AJ, Wenger GR, Craig CR, Stitzel RE. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice. The Journal of Pharmacology and Experimental Therapeutics. 180: 558-68. PMID 4258979 |
0.526 |
|
| 1971 |
Craig CR, Shideman FE. Metabolism and anticonvulsant properties of mephobarbital and phenobarbital in rats. The Journal of Pharmacology and Experimental Therapeutics. 176: 35-41. PMID 5569636 |
0.485 |
|
| Show low-probability matches. |